Canopy Rivers Announces Well being Canada Approval for Important Expansion to the Licensed Infrastructure at Radicle


TORONTOAug. 1, 2019 /CNW/ – Canopy Rivers Inc. (“Canopy Rivers” or the “Firm“) (TSXV: RIV) (OTC: CNPOF) is pleased to announce that its portfolio business Radicle Health-related Marijuana Inc. (“Radicle“) has received approval from Well being Canada for its production facility expansion project. This approval proficiently doubles Radicle’s production footprint, drastically growing its capacity to six,000 kilograms per year.

“We are thrilled with the continued development taking place at Radicle,” mentioned Narbe Alexandrian, President and CEO of Canopy Rivers. “The cannabis business is displaying several similarities to the craft beer movement, exactly where nearby, artisanal operators are succeeding in securing loyal and robust buyer followings. Radicle is thriving inside this craft segment, and is raising the bar when it comes to its exceptional strains presented beneath the Gage brand. We see no slowdown in customer demand for premium solutions and brands, and this Well being Canada approval will enable Radicle improved provide higher good quality craft cannabis to each the healthcare and adult-use markets.”

Initially licensed for cultivation in early 2018, Radicle’s indoor facility positioned in Hamilton, Ontario is focused on tiny-batch cultivation of exceptional genetic strains for its premium cannabis brand, Gage. With this Well being Canada approval, Radicle will have 40,000 sq. ft. devoted to indoor hydroponic cultivation. Radicle was 1 of the original twenty-six licensed cannabis producers chosen in a extremely competitive item get in touch with by the Ontario Cannabis Shop for adult-use sale on the net and in retail shops, and 1 of two entities chosen in spite of only getting a licence to cultivate at the time.

Canopy Rivers initial invested in Radicle in August 2017 and at present owns about 22% of the completely diluted issued and outstanding widespread shares of Radicle. Additional, Canopy Rivers is entitled to acquire a royalty primarily based on Radicle’s cannabis production, with a minimum annual payment of $900,000 per year for a term of 20 years. For additional details relating to the Company’s investment in Radicle, please refer to the Company’s annual details kind dated July 15, 2019(“AIF“), filed with Canadian securities regulators and readily available on Canopy Rivers’ profile on SEDAR at

About Canopy Rivers Inc.

Canopy Rivers is a exceptional investment and operating platform structured to pursue investment possibilities in the emerging international cannabis sector. Canopy Rivers identifies strategic counterparties in search of economic and/or operating assistance. Canopy Rivers has created an investment ecosystem of complementary cannabis operating firms that represent numerous segments of the worth chain across the emerging cannabis sector. As the portfolio continues to create, constituents will be offered with possibilities to operate with Canopy Development Corporation (TSX: WEED, NYSE: CGC) and collaborate amongst themselves, which Canopy Rivers believes will maximize worth for its shareholders and foster an atmosphere of innovation, synergy and worth creation for the whole ecosystem.

Forward-Searching Statements

This news release consists of statements which constitute “forward-hunting information” inside the which means of applicable securities laws, which includes statements relating to the plans, intentions, beliefs and existing expectations of the Firm with respect to future business enterprise activities and operating functionality. Forward-hunting details is normally identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or related expressions and contains details relating to the influence of the Well being Canada approval on Radicle’s production capacity and capacity to sell its cannabis solutions the region at Radicle that will be devoted to indoor hydroponic cultivation the development of the craft cannabis segment and Radicle’s capacity to thrive inside it customer demand for premium solutions and brands and expectations for other financial, business enterprise, and/or competitive elements.

Investors are cautioned that forward-hunting details is not primarily based on historical truth but alternatively reflects management’s expectations, estimates or projections regarding future final results or events primarily based on the opinions, assumptions and estimates of management deemed affordable at the date the statements are created. Although the Firm believes that the expectations reflected in such forward-hunting details are affordable, such details entails dangers and uncertainties, and undue reliance should really not be placed on such details, as unknown or unpredictable elements could have material adverse effects on future final results, functionality or achievements of the Firm. Amongst the essential elements that could lead to actual final results to differ materially from these projected in the forward-hunting details are the following: regulatory and licensing dangers the actual influence of the Well being Canada approval on Radical’s production capacity, cultivation space and cannabis item sales modifications in customer preferences and demand modifications in common financial, business enterprise and political situations, which includes modifications in the economic markets prospective conflicts of interest the Canadian regulatory landscape and enforcement connected to cannabis, which includes political dangers and dangers relating to regulatory alter modifications in applicable laws compliance with substantial government regulation public opinion and perception of the cannabis industry and the danger elements set out in the AIF, filed with Canadian securities regulators and readily available on the Company’s profile on SEDAR at

Need to 1 or additional of these dangers or uncertainties materialize, or should really assumptions underlying the forward-hunting details prove incorrect, actual final results may well differ materially from these described herein as intended, planned, anticipated, believed, estimated or anticipated. Though the Firm has attempted to determine significant dangers, uncertainties and elements that could lead to actual final results to differ materially, there may well be other folks that lead to final results not to be as anticipated, estimated or intended. The Firm does not intend, and does not assume any obligation, to update this forward-hunting details except as otherwise essential by applicable law.

Neither the TSX Venture Exchange nor its Regulation Solutions Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts duty for the adequacy or accuracy of this release.

Get Genuine-Time Updates from The Each day Marijuana Observer


Latest posts